iSpecimen Inc. Income Statement
ISPC|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
iSpecimen Inc. reported $9M in revenue and $12M in net loss for FY2025. Revenue has grown at a 3.2% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.90 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $9.3M | $9.9M | $10.4M | $11.1M | $8.2M |
| Cost of Revenue | $5.3M | $4.8M | $4.8M | $5.2M | $3.6M |
| SG&A Expense | $6.1M | $5.9M | $6.9M | $5.6M | $2.4M |
| R&D Expense | - | $1.6M | $1.5M | $879.2K | $319.2K |
| Operating Income | -$12.7M | -$11.2M | -$10.2M | -$5.9M | -$2.4M |
| Interest Expense | - | $18.0K | $239.0K | $2.1M | $2.1M |
| Income Tax | - | - | $0 | $0 | $0 |
| Net Income | -$12.5M | -$11.1M | -$10.2M | -$9.0M | -$4.7M |
| EPS (Basic) | -$17.58 | -$24.55 | -$1.16 | -$2.09 | -$4.97 |
| EPS (Diluted) | -$17.58 | -$24.55 | -$1.16 | -$2.09 | -$4.97 |
| Shares Outstanding | 1.7M | 454.2K | 8.9M | 8.7M | 936.2K |
| Operating Margin | -137.0% | -112.5% | -97.9% | -53.2% | -29.4% |
| Profit Margin | -134.5% | -111.8% | -98.5% | -80.5% | -56.8% |